Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > The Pathway to $ 9 !? - Corrected

<< Previous

Bullboard Posts

Next >>

Comment by Accountprinceon Sep 13, 2021 1:23pm

149 Views

Post# 33849163

RE:The Pathway to $ 9 !? - Corrected

Hi MM:

As always your calculations are spot on. Since no value ascribed to Dialco and assuming it has about the same value as PMX you're using a discount factor of 50% for both. Conservative given the advanced stages for both PMX and Dialco. I've always had a conservative estimate of $8 to $10 per share for Spectral so your $9 per share value is exactly the midpoint.

All signs point to the share price being ready for a run from the pathetic $.32 per share to the ultimate FMV starting soon. Should be exciting and rewarding.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages